Added Value of SPECT/CT in Post Lu-177 Dotatate Treatment for Neuroendocrine Tumors

被引：0
|
作者：
Couch, Paige [1 ]
Webb, Chelsea [2 ]
Botkin, Crystal [1 ]
Frye, Sarah [1 ]
Muzaffar, Razi [2 ]
Osman, Medhat [2 ]
机构：
[1] St Louis Univ, Nucl Med Technol Program, Dept Clin Hlth Sci, Doisy Coll Hlth Sci, St Louis, MO 63103 USA
[2] St Louis Univ, Dept Radiol, Div Nucl Med, St Louis, MO 63103 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
2044
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Quantitative SPECT/CT is predictive of 6-month RECIST response in midgut neuroendocrine tumors treated with 177Lu-DOTATATE
    Megherbi, I.
    Hoog, C.
    Morland, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S669 - S669
  • [32] Toxicity evaluation of 177Lu-DOTATATE for advanced neuroendocrine tumors
    Bonilla Plaza, J.
    Martinez Lorca, A.
    Navarro Martinez, T.
    Ajuria Illarramendi, O.
    Lopez Villar, I.
    Azpeitia Hernandez, P.
    Gutierrez Guerrero, M.
    Paredes Rodriguez, P.
    Orduna Diez, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S471 - S471
  • [33] Clinical Implementation of Lu-177 PSMA therapy, including SPECT/CT imaging post therapy
    Toderas, Larisa
    Chen, Delphine
    Iravani, Amir
    Scherzer, Zackary
    Erickson, Mark
    Miyaoka, Robert
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [34] Discordant Uptake Between Diagnostic 68Ga-HA-DOTATATE PET/CT and Posttherapy 177Lu-HA-DOTATATE SPECT/CT in Patients With Neuroendocrine Tumors
    Huizing, Daphne M. V.
    Aalbersberg, Else A.
    van der Hiel, Bernies
    Stokkel, Marcel P. M.
    Versleijen, Michelle W. J.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (09) : E475 - E477
  • [35] Quantitative Lu-177 SPECT/CT validation to assist theragnostic procedures
    Gnesin, S.
    Lima, T.
    Malterre, J.
    Verdun, F. R.
    Schaefer, N.
    Prior, J. O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S178 - S178
  • [36] A Case of Meningioma Applied Intraarterial Lu-177 DOTATATE
    Mammadli, K.
    Erkek, B. Karasah
    Parildar, M.
    Sanli, O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S660 - S660
  • [37] The clinical efficacy and effectiveness of the Lu-177 DOTATATE therapy
    Acar, E.
    Durak, H.
    Kaya, G. Capa
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S723 - S723
  • [38] Prognostic value of inflammation biomarkers for survival in patients with neuroendocrine tumors treated with [177Lu]Lu-DOTATATE
    Pineiro, A.
    Trivino Ibanez, E.
    Villa Palacios, J.
    Muros de Fuentes, M.
    Sanchez Sanchez, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S247 - S247
  • [39] Comparative evaluation of carrier added and non carrier added Lu-177 for preparation of therapeutic doses of Lu-177 radiopharmaceuticals
    Bhusari, P.
    Shukla, J.
    Singh, H.
    Sood, A.
    Mittal, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S688 - S688
  • [40] Treatment with the Radiolabelled Somatostatin Analog 177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
    Sansovini, Maddalena
    Severi, Stefano
    Ambrosetti, Alice
    Monti, Manuela
    Nanni, Oriana
    Sarnelli, Anna
    Bodei, Lisa
    Garaboldi, Lucia
    Bartolomei, Mirco
    Paganelli, Giovanni
    NEUROENDOCRINOLOGY, 2013, 97 (04) : 347 - 354
12345